Trinity Biotech (TRIB) Total Debt (2009 - 2025)
Trinity Biotech (TRIB) posted quarterly Total Debt of $420000.0 for Q2 2025, little changed year-on-year from $420000.0 in Q2 2024, and little changed on a QoQ basis from $420000.0 in Q4 2024.
Trinity Biotech (TRIB) Total Debt (2009 - 2025) Analysis & Trends
Trinity Biotech (TRIB) has reported Total Debt for 15 consecutive years, with $420000.0 the latest figure, recorded in Q2 2025.
- Quarterly Total Debt changed 0.0% year-over-year to $420000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $420000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $420000.0, changed 0.0% from the prior year.
- Total Debt steadied at $420000.0 in Q2 2025 per TRIB's latest filing, from $420000.0 in the prior quarter.
- Over the last five years, Total Debt for TRIB reached as high as $166.6 million in Q4 2021 and fell as low as $210000.0 in Q3 2022.
- A 5-year average of $31.8 million and a median of $420000.0 in 2023 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2021 — Total Debt surged 101.49% — and 2022, when it plunged 99.87%.
- Year by year, Total Debt stood at $166.6 million in 2021, then tumbled by 99.87% to $210000.0 in 2022, then surged by 100.0% to $420000.0 in 2023, then changed by 0.0% to $420000.0 in 2024, then changed by 0.0% to $420000.0 in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $420000.0, $420000.0, and $210000.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.48 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.14 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 420,000.00 |
| Dec 31, 2024 | 420,000.00 |
| Sep 30, 2024 | 210,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | 210,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Jun 30, 2023 | 210,000.00 |
| Mar 31, 2023 | 210,000.00 |
| Dec 31, 2022 | 210,000.00 |
| Sep 30, 2022 | 210,000.00 |
| Jun 30, 2022 | 44.20 Mn |
| Mar 31, 2022 | 76.25 Mn |
| Dec 31, 2021 | 166.62 Mn |
| Sep 30, 2021 | 83.16 Mn |
| Jun 30, 2021 | 83.19 Mn |
| Mar 31, 2021 | 84.05 Mn |
| Dec 31, 2020 | 82.70 Mn |
| Sep 30, 2020 | 83.06 Mn |
| Jun 30, 2020 | 82.90 Mn |